Since it has been demonstrated that tumor-derived soluble MICA can negatively impact NK cell cytotoxicity by modulating the NKG2D pathway [25, 26], we investigated if high serum levels of soluble MICA in patients with PD was correlated with a downregulation of NK activation and cytotoxic markers. Here, KLRK1 is linked to neoplasm.